Status
Conditions
Study type
Funder types
Identifiers
About
We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data and blood samples from a control group for comparator purposes. In doing so, we will be able to describe the "phenotypic" expression of these diseases.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Vanita Patel, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal